[Hypertrophic obstructive cardiomyopathy].

H Goos; B Krosse; P Ewers

Home/Archive/PubMed

PubMed · 2198722

[Hypertrophic obstructive cardiomyopathy].

H Goos·B Krosse·P Ewers

View original source ↗Export metadata ↓

Abstract

Today, with the help of modern echocardiographic techniques we are able not only to describe the characteristic changes when a HOCM is present and to determine the intracavitary pressure gradient, but also recognize the functional irregularities typical for the HOCM. Thus, the methodical progress of the echocardiography has essentially enlarged our knowledge about the pathophysiology of this clinical picture. Today, the echocardiography is the method of choice for the diagnostics of the HOCM and for the judgment of the functional consequences of therapeutic interventions.

Explore related subjects

Cardiomyopathy, Hypertrophic Echocardiography Echocardiography, Doppler Heart Septum Heart Ventricles Humans English Abstract Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

H Goos, B Krosse, P Ewers. 1990-05-01. [Hypertrophic obstructive cardiomyopathy].. https://pubmed.ncbi.nlm.nih.gov/2198722/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Percutaneous septal ablation with absorbable gelatin sponge in hypertrophic obstructive cardiomyopathy.

The treatment of the hypertrophic obstructive cardiomyopathy (HOCM) by percutaneous transluminal septal myocardial ablation (PTSMA) with ethanol injection has greatly improved in the last years. This report describes the case of a patient with symptomatic drug-refractory HOCM who underwent an unsuccessful attempt to thrombose the septal artery by PTSMA with alcohol. It has therefore been decided to use small absorbant gelatin sponge (AGS) particles, obtaining immediate thrombotic occlusion of the artery and excellent hemodynamic results with immediate and permanent disappearance of the gradient. The patient progressed satisfactorily and displayed lower than average creatine kinase levels in comparison to the rest of our PTMSA patients. After 2 years of follow-up he still remains asymptomatic and without any gradient. These results suggest that PTSMA with AGS could be a valuable alternative treatment of HOCM.

Cardiomyopathy, Hypertrophic↗

PubMed2007

Left ventricular dynamic obstruction by atypical papillary muscle morphology: is this finding so unusual in clinical practice?

Explore the source record for details and available documents.

Cardiomyopathy, Hypertrophic↗

PubMed2006

Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study.

AIMS: Diabetes in pregnant women is increasing and with that the complications in their offspring. We studied our population of diabetic mothers (2003-2005) for pathologic ventricular hypertrophy (PVH). METHODS AND RESULTS: In our retrospective study of all 87 diabetic pregnancies (92 neonates), 16 were type 1, 17 were type 2, and 54 were gestational diabetes (GD). Haemoglobin glycated (HbA1c) median was 5.8% (5.3-6.5): 17 with HbA1c above normal 2 with congenital heart disease (CHD) and six with PVH. A total of 75 neonates were normal, five had CHD, and 12 had PVH (1/12 died post-natally, 1/12 stillborn, 2/12 required premature delivery, 8/12 normal). The 16 type 1 pregnancies resulted in three neonates with CHD and in 50% PVH, including one death, one premature Cesarean section because of PVH. The 17 neonates of type 2 pregnancies showed in one CHD and in 25% PVH. Of the 54 GD pregnancies, one had CHD and one had PVH. CONCLUSION: Pregnancies of both type 1 and 2 diabetes carry an increased risk for foetal development of PVH compared with those with GD. The insufficient effect of preventive glycaemia controls leads to conclude that although no definite predictive parameters for malignant outcome can be presented, close monitoring of these pregnancies may prevent perinatal catastrophes.

Cardiomyopathy, Hypertrophic↗